Elsevier

Neuropharmacology

Volume 107, August 2016, Pages 181-188
Neuropharmacology

Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol

https://doi.org/10.1016/j.neuropharm.2016.03.027Get rights and content

Highlights

  • The anti-inflammatory cytokine IL-10 rapidly regulates GABAergic transmission.

  • PI3K is involved in postsynaptic regulation of GABAA receptors by IL-10.

  • Brain IL-10 content is increased 1 h after a single intoxicating dose of EtOH.

  • IL-10 regulates EtOH sensitivity by reducing acute EtOH-induced hypnosis.

  • Early increases in IL-10 may contribute to disrupted sleep following EtOH exposure.

Abstract

Mounting evidence indicates that ethanol (EtOH) exposure activates neuroimmune signaling. Alterations in pro-inflammatory cytokines after acute and chronic EtOH exposure have been heavily investigated. In contrast, little is known about the regulation of neurotransmission and/or modulation by anti-inflammatory cytokines in the brain after an acute EtOH exposure. Recent evidence suggests that interleukin-10 (IL-10), an anti-inflammatory cytokine, is upregulated during withdrawal from chronic EtOH exposure. In the present study, we show that IL-10 is increased early (1 h) after a single intoxicating dose of EtOH (5 g/kg, intragastric) in Sprague Dawley rats. We also show that IL-10 rapidly regulates GABAergic transmission in dentate gyrus neurons. In brain slice recordings, IL-10 application dose-dependently decreases miniature inhibitory postsynaptic current (mIPSC) area and frequency, and decreases the magnitude of the picrotoxin sensitive tonic current (Itonic), indicating both pre- and postsynaptic mechanisms. A PI3K inhibitor LY294002 (but not the negative control LY303511) ablated the inhibitory effects of IL-10 on mIPSC area and Itonic, but not on mIPSC frequency, indicating the involvement of PI3K in postsynaptic effects of IL-10 on GABAergic transmission. Lastly, we also identify a novel neurobehavioral regulation of EtOH sensitivity by IL-10, whereby IL-10 attenuates acute EtOH-induced hypnosis. These results suggest that EtOH causes an early release of IL-10 in the brain, which may contribute to neuronal hyperexcitability as well as disturbed sleep seen after binge exposure to EtOH. These results also identify IL-10 signaling as a potential therapeutic target in alcohol-use disorders and other CNS disorders where GABAergic transmission is altered.

Introduction

A growing body of evidence from behavioral, molecular, genomic and electrophysiological studies indicates that ethanol (EtOH) exposure activates neuroimmune signaling (Crews et al., 2011, Mayfield et al., 2013, Bajo et al., 2015a). A number of hypotheses exist as to how EtOH causes increased activation of pro-inflammatory cytokines. For example, EtOH-induced liposaccharide (LPS) release into the systemic circulation and increased high-mobility group box 1 (HMGB1) protein release from neurons are implicated, both of which increase toll-like receptor 4 activity (Wang et al., 2010, Zou and Crews, 2014). This activity causes microglial activation, leading to further expression of pro-inflammatory genes, that are associated with increased alcohol consumption (Mayfield et al., 2013). Thus, mice treated with a high EtOH dose show an increase in systemic levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNFα) and monocyte chemoattractant protein-1 (MCP-1), accompanied with a persistent increase in pro-inflammatory cytokines in the brain (Norkina et al., 2007, Qin et al., 2008). EtOH preference and amount of EtOH consumed are significantly reduced in mice lacking interleukin-1 receptor antagonist (IL-1ra) and in interleukin-6 (IL-6) knockout mice (Blednov et al., 2012).

In addition to neuroimmune modulation after EtOH exposure, cytokines and their receptors regulate neurotransmission and synaptic plasticity (Vezzani and Viviani, 2015), including ligand-gated ion channel trafficking and function via kinase-dependent mechanisms (Viviani et al., 2003, Yang et al., 2005). TNFα acts on neuronal TNFR1 by a phosphatidylinositol-3-kinase (PI3K) mechanism to exocytose AMPA receptors (AMPAR), thereby increasing excitatory neurotransmission in hippocampal neurons (Stellwagen et al., 2005). Conversely, TNFα causes endocytosis of GABAA receptors (GABAARs) (Stellwagen et al., 2005). Another pro-inflammatory cytokine, interleukin-1β (IL-1β), reduces the frequency of AMPAR-dependent excitatory synaptic currents, but enhances NMDAR-mediated currents by activation of tyrosine kinases (Viviani et al., 2003, Yang et al., 2005). In addition, the IL-1 receptor 1 (IL-1R1) and NMDA receptor families interact with each other (Gardoni et al., 2011). IL-1β also increases recruitment of GABAARs to cell-surface via IL-1R1-dependent PI3K activation, causing a delayed enhancement of GABA currents (Serantes et al., 2006). Overall, investigations of GABAAR indicate that the two pro-inflammatory cytokines TNFα and IL-1β diminish and augment inhibitory synaptic transmission, respectively.

In contrast to pro-inflammatory cytokines, less is known about the regulation of neurotransmission and/or modulation of anti-inflammatory cytokines in the brain after acute EtOH exposure. Indeed, recent investigations show that IL-1ra, an endogenous anti-inflammatory factor, regulates GABAergic transmission in central nucleus of amygdala and EtOH effects on synaptic activity (Bajo et al., 2015b). Also, mice lacking IL-1ra show reduced EtOH consumption (Blednov et al., 2015). In this study, we focused on interleukin-10 (IL-10), an anti-inflammatory cytokine. The −592C > A IL-10 gene polymorphism is associated with alcoholism in Spanish subjects (Marcos et al., 2008). A recent human study showed that after a single binge EtOH exposure, LPS-induced pro-inflammatory state is followed by an anti-inflammatory state in blood samples collected 2–5 h post-binge (Afshar et al., 2015). A single 24 h incubation with EtOH (25 mM) also increases IL-10 production by human monocytes (Norkina et al., 2007). In a 4-day binge EtOH model, hippocampal IL-10 levels were upregulated 7 days after withdrawal (Marshall et al., 2013). Interestingly, no blood-brain-barrier (BBB) disruption or upregulation of hippocampal pro-inflammatory cytokines occurred at this time point. Despite increases peripherally from acute exposure and centrally from chronic exposure, much remains unknown about alterations in anti-inflammatory cytokines in the brain after a single binge EtOH exposure and their possible modulation of GABAergic neurotransmission.

In the current study, we examine the effects of a single intoxicating dose of EtOH on rat hippocampal IL-10 levels. We also examine IL-10 effects on inhibitory tonic and phasic GABAergic currents in hippocampal dentate gyrus (DG) neurons and the involvement of PI3-kinase in these effects. Finally, we examine the behavioral contributions of IL-10 to EtOH's hypnotic responses, which may reflect neuroimmune modulation of sleep. Overall, these results suggest that early increases in brain IL-10 after a single intoxicating dose of EtOH may contribute to disrupted sleep following EtOH exposure.

Section snippets

Animals

All animal experiments followed the Institutional Animal Care and Use Committee approved protocols. Newborn mixed-sex pups from Sprague Dawley breeding pairs (250–300 g, Harlan) were used for preparation of primary neuron cultures. Male adult Sprague Dawley rats were used for hippocampal slice recordings and behavioral studies (200–250 g; Harlan and Taconic, respectively).

Cultured cerebral cortical neurons

Primary cultures of rat cerebral cortical neurons were prepared from rat pups on postnatal day 0–1 and maintained for 18–24

A single intoxicating dose of EtOH increases hippocampal IL-10 levels

Preliminary in vitro studies were carried out in supernatant, i.e. sample media collected from rat primary cultured cortical neurons. EtOH (50 mM) exposure for 4 h increased IL-10 from 82.29 ± 25.19 pg/ml (untreated cultures) to 175.07 ± 60.92 pg/ml (Fig. 1A). IL-10 levels were attenuated after incubation with a rat IL-10 neutralizing antibody (Fig. 1A). Based on these preliminary data we continued our studies in adult rats. We have previously shown that peak plasma [EtOH] of ∼60 mM

Discussion

We show that brain content of the anti-inflammatory cytokine IL-10 is increased 1 h after a single intoxicating dose of EtOH. We also identify a novel rapid regulation of GABAergic transmission by IL-10 in cortical and hippocampal neurons, via both pre- and postsynaptic mechanisms. The postsynaptic effect appears to be PI3K-dependent. Reduced sleep quality is one of the most prominent effects of acute EtOH withdrawal and is likely due to hyperexcitability, but the mechanisms involved are

Conflicts of interest

The authors declare no competing financial interests.

Acknowledgements

This work was supported by Dept. of Pharmaceutical Sciences at University of the Sciences and Milton Lev Memorial Foundation funds (A.S.), Psychology Department, Binghamton University (D.W.), P60-AA11605 (ALM), AA016100, AA022408, and AA022707 (I.S.).

References (59)

  • A.J. Kwilasz et al.

    The therapeutic potential of interleukin-10 in neuroimmune diseases

    Neuropharmacology

    (2015)
  • B. Luscher et al.

    GABAA receptor trafficking-mediated plasticity of inhibitory synapses

    Neuron

    (2011)
  • S.A. Marshall et al.

    Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: the importance of microglia phenotype

    Neurobiol. Dis.

    (2013)
  • J. Mayfield et al.

    Neuroimmune signaling: a key component of alcohol abuse

    Curr. Opin. Neurobiol.

    (2013)
  • I. Mody et al.

    Diversity of inhibitory neurotransmission through GABA(A) receptors

    Trends Neurosci.

    (2004)
  • M.M. Naiyer et al.

    Identification and characterization of a human IL-10 receptor antagonist

    Hum. Immunol.

    (2013)
  • J. Neasta et al.

    AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors

    Biol. Psychiatry

    (2011)
  • M.R. Opp et al.

    Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep

    J. Neuroimmunol.

    (1995)
  • I. Popovici et al.

    Binge drinking and sleep problems among young adults

    Drug Alcohol Depend.

    (2013)
  • R.V. Schunck et al.

    Protracted alcohol abstinence induces analgesia in rats: possible relationships with BDNF and interleukin-10

    Pharmacol. Biochem. Behav.

    (2015)
  • R. Serantes et al.

    Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy

    J. Biol. Chem.

    (2006)
  • S. Sharma et al.

    IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways

    Brain Res.

    (2011)
  • K. Strle et al.

    IL-10 promotes survival of microglia without activating Akt

    J. Neuroimmunol.

    (2002)
  • E.A. Tukhovskaya et al.

    Anti-inflammatory cytokine interleukin-10 increases resistance to brain ischemia through modulation of ischemia-induced intracellular Ca(2)(+) response

    Neurosci. Lett.

    (2014)
  • A. Vezzani et al.

    Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability

    Neuropharmacology

    (2015)
  • Y. Wu et al.

    Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment

    Brain Behav. Immun.

    (2011)
  • S. Yang et al.

    Interleukin-1beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission

    Brain Res.

    (2005)
  • M. Atzori et al.

    Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: experimental evidence and therapeutic implications

    Future Med. Chem.

    (2012)
  • M. Bajo et al.

    IL-1 interacts with ethanol effects on GABAergic transmission in the mouse central amygdala

    Front. Pharmacol.

    (2015)
  • Cited by (0)

    View full text